|Daily Range||$12.59 - $13.67|
|52-Week Range||$12.04 - $38.10|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||340,750|
|Current FY EPS||-$6.41|
Coherus BioSciences, Inc. (CHRS) Description
Coherus BioSciences, Inc. Website: http://www.coherus.com/
News & Commentary
A new biosimilar generic alternative to the multibillion blockbuster Enbrel could hit pharmacy shelves next year.
Our contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.